A groundbreaking collaboration between Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and the Frederick National Laboratory for Cancer Research is revolutionizing cancer treatment and supercomputer-aided drug discovery. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more: https://livermorelab.info/3yXVa0e | Lawrence Livermore National Laboratory
3:30
A groundbreaking collaboration between Lawrence Livermore Nati…
2K viewsJun 6, 2024
FacebookLawrence Livermore National Laboratory
Meet the PAL – Justin
1:05
Meet the PAL – Justin
67 views5 months ago
YouTubeBridgeBio
Meet the PAL – Larizza
1:34
Meet the PAL – Larizza
45 views5 months ago
YouTubeBridgeBio
Meet the PAL – Rich
1:07
Meet the PAL – Rich
65 views5 months ago
YouTubeBridgeBio
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
LLNL and BridgeBio announce trials for supercomputing-discovered c…
5 months ago
llnl.gov
How BridgeBio Transformed Compliance With Egnyte’s GxP Compliant Platform
1:52
How BridgeBio Transformed Compliance With Egnyte’s GxP C…
114 views10 months ago
YouTubeEgnyte
EP 212: A hub-and-spoke model for accelerating rare disease drug development with BridgeBio
48:37
EP 212: A hub-and-spoke model for accelerating rare disease drug de…
74 views4 months ago
YouTubeSano Genetics
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
138 views7 months ago
YouTubeMelissa Bime
Cómo invertir en BridgeBio Oncology Therapeutics Inc (BBOT)
1:31
Cómo invertir en BridgeBio Oncology Therapeutics Inc (BBOT)
1 week ago
YouTubeAprende a Invertir
BridgeBio bondit en Bourse après des résultats « idéaux » pour son traitement expérimental contre une maladie musculaire rare
BridgeBio bondit en Bourse après des résultats « idéaux » pour son …
4 months ago
zonebourse.com
Mechanism of disease of LGMD2I/R9
1:58
Mechanism of disease of LGMD2I/R9
274 views4 months ago
YouTubeBridgeBio
Lawrence Livermore National Lab on Instagram: "In a milestone for supercomputing-aided drug design, @Livermore_lab and BridgeBio Oncology Therapeutics announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more at the link in our bio."
3:29
Lawrence Livermore National Lab on Instagram: "In a milestone for …
5K viewsJun 6, 2024
Instagramlivermore_lab
BridgeBio Oncology Therapeutics Rings the Closing Bell
BridgeBio Oncology Therapeutics Rings the Closing Bell
5 months ago
nasdaq.com
Another Year of Purpose and Progress: On Rare Looks Back at 2025
36:42
Another Year of Purpose and Progress: On Rare Looks Back at …
63 views2 months ago
YouTubeBridgeBio
BridgeBio Introduces - On Rare
1:21
BridgeBio Introduces - On Rare
62 viewsMar 3, 2025
YouTubeBridgeBio Pharma
BridgeBio Phase 3 Win • FDA HRT Label Shift • Universal Flu Trial
7:17
BridgeBio Phase 3 Win • FDA HRT Label Shift • Universal Flu Trial
3 weeks ago
YouTubeBioMed Nexus
Academia + Industry with BridgeBio's Dr. Michael Henderson
45:16
Academia + Industry with BridgeBio's Dr. Michael Henderson
583 viewsJun 21, 2021
YouTubeLife Science Connect
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress…
Jan 13, 2025
finanznachrichten.de
BridgeBio Pharma, Inc.: BridgeBio Announces Infigratinib Is the First Ever Investigational Therapeutic Option for Achondroplasia to Be Awarded Breakthrough Therapy Designation by the FDA
BridgeBio Pharma, Inc.: BridgeBio Announces Infigratinib Is the Firs…
Sep 17, 2024
finanznachrichten.de
BridgeBio Oncology Therapeutics (BBOT) @ JPM 2026 第44届摩根大通医疗保健会议
33:05
BridgeBio Oncology Therapeutics (BBOT) @ JPM 2026 第44届摩根大 …
28 views2 months ago
bilibilibili_42520431755
Putting Patients First: BridgeBio Founder & CEO, Neil Kumar, Ph.D. at Milken 2025
8:32
Putting Patients First: BridgeBio Founder & CEO, Neil Kumar, Ph.D…
758 views10 months ago
YouTubeBridgeBio
BridgeBio Pharma Reports Phase 3 Data Linking TTR Increase to Improved Survival With Acoramidis
BridgeBio Pharma Reports Phase 3 Data Linking TTR Increase to Impr…
10 months ago
marketscreener.com
LGMD2I/R9 can’t be diagnosed based on symptoms alone. It requires genetic confirmation. That’s why no-cost genetic testing is now available for those who may have #LGMD. A confirmed diagnosis can lead to support, community, and connection to research. ➡️ Learn more: https://bit.ly/3VnyNJM | BridgeBio
0:17
LGMD2I/R9 can’t be diagnosed based on symptoms alone. It requ…
103 views4 months ago
FacebookBridgeBio
BridgeBio About Us
9:55
BridgeBio About Us
62 viewsDec 13, 2023
VimeoBridgeBio
[바이오팟동영상] 브릿지바이오 이정규 대표 - Bridge Biotherapeutics, Inc.
12:07
[바이오팟동영상] 브릿지바이오 이정규 대표 - Bridge Biotherapeutics, Inc.
701 viewsJun 19, 2017
YouTube뉴스1TV
BridgeBio's oral drug improves growth in children with dwarfism in late-stage study
BridgeBio's oral drug improves growth in children with dwarfism i…
1 month ago
marketscreener.com
Careers
Careers
Feb 28, 2025
bridgebio.com
From Diagnosis to Treatment: Eric's ATTR-CM Journey
3:48
From Diagnosis to Treatment: Eric's ATTR-CM Journey
196 views11 months ago
YouTubeBridgeBio
BridgeBio Lines Up Another 'Domino' As It Nears A Record High
BridgeBio Lines Up Another 'Domino' As It Nears A Record High
4 months ago
investors.com
Founder Stories: Neil Kumar - founder and CEO of BridgeBio
1:01:15
Founder Stories: Neil Kumar - founder and CEO of BridgeBio
2.7K viewsJun 14, 2020
YouTubeAxial
See more